Christopher Reinhard

Christopher Reinhard

Directeur Général chez
Taxus Cardium Pharmaceuticals Group, Inc.
72 ans
Health Technology
Finance
Producer Manufacturing

Profil

Christopher J.
Reinhard
was the founder of Collateral Therapeutics, Inc., founded in 1996, where the title held was Chief Executive Officer in 2002.
Mr. Reinhard is the founder of Gene Biotherapeutics, Inc., founded in 2003, where the title held is Chief Executive Officer.
The current job is Chief Executive Officer at Tissue Repair Co. since 2013, with employment starting in 2006.
Former jobs include Chairman, President, CEO, CFO & Treasurer at Aries Ventures, Inc. from 2005 to 2006; Chief Executive Officer & Director at Post-Hypothermia Corp.
from 2006 to 2009; Chief Executive Officer & Director at To Go Brands, Inc. from 2012 to 2013; Executive Chairman at Artes Medical, Inc. from 2004 to 2008; Director at Ontro, Inc.; Managing Director & Vice President at The Henley Group, Inc. (New Hampshire); Vice President at IMED Corp; Vice President at Instrumentation Laboratory Co.; Vice President at Fisher Scientific Group, Inc. Education includes undergraduate and MBAistration degrees from Babson College.

Postes actifs de Christopher Reinhard

SociétésPosteDébut
Directeur Général 22/12/2003
Directeur Général 01/01/2013

Anciens postes connus de Christopher Reinhard

SociétésPosteFin
Directeur Général 01/11/2013
Directeur Général 01/07/2009
Président 01/01/2008
Directeur Général 23/01/2006
Fondateur 03/07/2002
Voir l'expérience en détail de Christopher Reinhard

Formation de Christopher Reinhard

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

41

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Finance

Producer Manufacturing

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Fisher Scientific Group, Inc.

  1. Bourse
  2. Insiders
  3. Christopher Reinhard
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT